Grateful for this award from MASCC. We have been working closely with @RichPaxman to build a device to reduce chemotherapy induced peripheral neuropathy. Awaiting results from the ICE COMPRESS trial. This has been a massive team effort!

RT @ArndtVogel: Gastric cancer.@TheLancet .👏Excellent and comprehensive summary from screening to targeted therapie….

RT @KoheiShitara: A tribute to Dr. Agatsuma was a meaningful moment during my DESTINY-Gastric04 presentation at #ASCO25 with @NEJM publicat….

RT @LizzySmyth1: 📢It's #ESMO election time!. I am delighted to be nominated for ESMO Director of Education 😊. ALL the nominees are fantasti….

RT @YoujiaZhong: Cancer patients with B cell malignancies and differential expression of CD24, CDK14 and PLEKHG1 have highest risk of brea….

Thrilled to share our latest Review on Gastric Cancer in the @TheLancet covering the latest in the treatment and management of this illness @LizzySmyth1 @KoheiShitara @HannekevanLaar1 @MarkarSheraz @YJanjigianMD & Izuma Nakayama.

String of #AACR25 posts coming up! Proud of the work by @josephjzhao unraveling epigenetic mechanisms of peritoneal metastases in gastroesophageal cancers. @KlempnerSam @JohnnyOngCA

Published today simultaneously with #AACR25 our work on colorectal cancer peritoneal metastases in Clinical Cancer Research. slowly heading toward the goal of treating this difficult disease with novel therapeutics

Grateful to be given the opportunity to share our work on tumor evolution in gastric cancer and peritoneal metastases at #AACR25 with Dr Sun Young Rha @KlempnerSam @josephjzhao @choong_kun

RT @YaleCancer: .@sundar__raghav shares how spatial heterogeneity is driven to an evolution over space and time in #gastriccancer. As the t….

RT @ElizSMcKenna: Read more about #AACR25 speaker @sundar__raghav's efforts to chart gastric cancer evolution through tumor ecosystems and….

Excited to be in Chicago for #AACR25! Feels a little surreal to be at McCormick but not for ASCO! Looking forward to listening to some amazing science and breakthroughs in cancer biology and therapeutics. @KlempnerSam @josephjzhao

RT @YaleCancer: This afternoon starting at 2pm CDT, Drs. Barbara Burtness, @moeinrajaei, @JeffTownsend, Longgang Zhao, and @sundar__raghav….

RT @YaleCancer: Thursday, April 24 at 6pm, @sundar__raghav will moderate the next @YaleGICancers CME Webinar spotlighting #Gastroesophageal….

Honored to give the Keynote lecture at the Sixth Annual Paul R. O’Hara Esophagogastric Symposium in the University of Colorado Cancer Center. Sharing our work in gastroesophageal cancer and peritoneal metastases. Many thanks to @SunnieSKim for inviting me to speak!

RT @CD_AACR: From the April issue:Spatially Resolved Tumor Ecosystems and Cell States in Gastric Adenocarcinoma Progression and Evolution h….

RT @KoheiShitara: Excited to share biomarker analysis of CM649 @NatureMedicine @YJanjigianMD Nivo benefit was enriched in TMB-H> EBV and G….

RT @KoheiShitara: Mattehorn study showed EFS improvement and strong OS trend with FLOT+duravalumab. Great news to establish the global stan….

Just published @JAMAJournal with @KlempnerSam and @JeeyunM Our Editorial on GEMSTONE-303 with sugemalimab and chemo. Key takeaway: PD-L1 inhibition shows similar efficacy to PD-1. More options for patients, but no clear advantage over existing treatments.

Shifting focus to B-cells in gastric cancer: Our study examines multiple cohorts and employs spatial profiling. This provides fresh insights into the tumor microenvironment, complementing T-cell focused studies of the TME @RyanYKTay @josephjzhao.